8-Methyl-4H-1,3-benzodioxin | 90674-27-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并二恶烷
• 英文名称: 8-Methyl-4H-1,3-benzodioxin
• 英文别名: 8-methyl-4H-1,3-benzodioxine
• CAS: 90674-27-4
• 化学式: C₉H₁₀O₂
• 分子量: 150.17
• InChiKey: VBPCDCUYPBFUET-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• COMPOUNDS HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY
  申请人：Sakagami Masahiro

  公开号：US20110028468A1

  公开（公告）日：2011-02-03

  This invention provides a compound of the formula (I): a pharmaceutically acceptable salt or solvate thereof, wherein R 1 is substituted or unsubstituted alkyl or the like, R 2 is hydrogen or substituted or unsubstituted alkyl, Ring A is monocyclic or bicyclic aromatic heterocycle, R 3 is substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or substituted or unsubstituted heterocycle, R 4 is halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl or the like, m is an integer between 0 and 2, n is an integer between 0 and 5, R is halogen, oxo, cyano, nitro, substituted or unsubstituted alkyl or the like, and p is an integer between 0 and 2 as novel compounds having NPY Y5 antagonistic activity.

  这项发明提供了式(I)的化合物： 其药学上可接受的盐或溶剂化合物， 其中 R1为取代或未取代的烷基或类似物， R2为氢或取代或未取代的烷基， 环A为单环或双环芳香杂环， R3为取代或未取代的芳基，取代或未取代的杂芳基或取代或未取代的杂环， R4为卤素，氰基，取代或未取代的烷基，取代或未取代的环烷基或类似物， m为0到2之间的整数， n为0到5之间的整数， R为卤素，氧代，氰基，硝基，取代或未取代的烷基或类似物，以及 p为0到2之间的整数 作为具有NPY Y5拮抗活性的新化合物。
• ANALOGS OF DEHYDROPHENYLAHISTINS AND THEIR THEAPEUTIC USE
  申请人：Palladino Michael A.

  公开号：US20080221122A1

  公开（公告）日：2008-09-11

  Compounds represented by the following structure (II) are disclosed: as are methods for making such compounds. Compositions and methods for treating various disease conditions including cancer and non-cancer diseases associated with vascular proliferation are also disclosed.

  由以下结构（II）表示的化合物已被披露：制备这种化合物的方法也已被披露。还披露了用于治疗各种疾病条件的组合物和方法，包括与血管增殖相关的癌症和非癌症疾病。
• Analogs of dehydrophenylahistins and their therapeutic use
  申请人：Palladino Michael

  公开号：US20070078138A1

  公开（公告）日：2007-04-05

  Compounds represented by the following structure (II) are disclosed: as are methods for making such compounds. Compositions and methods for treating various disease conditions including cancer and non-cancer diseases associated with vascular proliferation are also disclosed.

  本文揭示了由以下结构（II）所代表的化合物，以及制造这种化合物的方法。此外，还揭示了用于治疗各种疾病状况的组合物和方法，包括与血管增殖有关的癌症和非癌症疾病。
• Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation
  申请人：Naccari Giancarlo

  公开号：US20090258837A1

  公开（公告）日：2009-10-15

  The invention relates to analogous compounds of 6-thioguanosine triphosphate of general formula (I). A compound of the general formula (I); wherein the dashed bond in the sugar moiety can be either single or double and wherein R1, R2, R3, R4 or R5, equal or different between each other, have general formula -(Int) m -Ter, wherein m is between 0 and 12 and Int and Ter are Internal and Terminal building blocks, wherein Int is selected from the group consisting of formula (II); and Ter is selected from the group consisting of formula (III). And wherein X represents either carbon or nitrogen atom within aromatic ring, Y represents either oxygen or sulphur atom and an additional group Q, group Qi or groups Qi (Qi indicates that the group or several groups may be bound to any unsaturated moiety of the ring) are selected from the group consisting of —OH, —COOH, —N(CH 3 ) 2 , —N(CH 2 —CH 3 ) 2 |—CO—CH 3 , —CO—O—CH 3 , —O—CH 3 , —S—CH 3 , —SO 2 —CH 3 , —CN, —NO 2 or -Halogen elements, and wherein R5 may be formula (IV) and metal and ammonium salts thereof, wherein n is between O and 5, or oxygen or phosphorus is partially or completely replaced by nitrogen, sulphur, methyleno groups or their derivatives. The invention also concerns the uses of the above mentioned compounds in medical field and the process for their preparation.

  本发明涉及6-硫鸟嘌呤三磷酸类似化合物，其通式为(I)。通式(I)的化合物中，糖基中的虚线键可以是单键或双键，其中R1、R2、R3、R4或R5，相互之间相同或不同，具有通式-(Int)m-Ter，其中m在0到12之间，Int和Ter是内部和末端构建块，其中Int从公式(II)所示的群组中选择；Ter从公式(III)所示的群组中选择。其中X代表芳香环内的碳或氮原子，Y代表氧或硫原子，以及附加基团Q、Qi基团或Qi基团（Qi表示该基团或若干基团可以结合到环的任何不饱和基团上）从以下群组中选择：—OH、—COOH、—N（CH3）2、—N（CH2—CH3）2、—CO—CH3、—CO—O—CH3、—O—CH3、—S—CH3、—SO2—CH3、—CN、—NO2或卤素元素，其中R5可以是公式(IV)及其金属和铵盐，其中n在0到5之间，或氧或磷部分或完全被氮、硫、亚甲基基团或其衍生物所取代。本发明还涉及上述化合物在医学领域中的用途以及它们的制备方法。
• Selective Ligands for the Dopamine 3 (D3) Receptor and Methods of using the Same
  申请人：Wang Shaomeng

  公开号：US20110184033A1

  公开（公告）日：2011-07-28

  Potent and selective ligands for the dopamine 3 (D 3 ) receptor are disclosed. The D3 receptor ligands have a structural formula (I) wherein X is C═O or SO 2 , R 1 is C 1-6 alkyl, R 2 is aryl, heteroaryl, aryl, —(CH 2 ) 1-3 aryl, or —(CH 2 ) 1-3 heteroaryl, and n is 0 or 1. Methods of using the D 3 receptor ligands in the treatment of diseases and conditions wherein modulation of the D 3 receptor provides a benefit also are disclosed.

  揭示了对多巴胺3（D3）受体具有强效和选择性的配体。D3受体配体具有结构式（I），其中X是C═O或SO2，R1是C1-6烷基，R2是芳基，杂环芳基，芳基，—（CH2）1-3芳基或—（CH2）1-3杂环芳基，n为0或1。还揭示了在调节D3受体提供益处的疾病和病况的治疗中使用D3受体配体的方法。